Leaflet LARTOKAZ 300mg / 25mg tablets


Indicated for: hypertension

Route of administration: oral

Substance: irbesartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)

ATC: C09DA04 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Photosensitivity
Photosensitivity

Avoid excessive exposure to sunlight or UV radiation.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of irbesartan and hydrochlorothiazide is used to treat essential hypertension in patients who do not respond adequately to monotherapy. Irbesartan is an angiotensin II receptor antagonist that helps relax blood vessels, while hydrochlorothiazide is a diuretic that reduces fluid volume in the body, thereby lowering blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include dizziness, fatigue, nausea, or electrolyte imbalances. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about LARTOKAZ 300mg / 25mg

  • Substance: irbesartan + hydrochlorothiazide
  • Date of last drug list: 01-07-2013
  • Commercial code: W57024001
  • Concentration: 300mg / 25mg
  • Pharmaceutical form: tablets
  • Quantity: 14
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for irbesartan + hydrochlorothiazide

Concentrations available for irbesartan + hydrochlorothiazide

  • 150mg/12.5mg
  • 300mg/12.5mg
  • 300mg/25mg